Autolus Therapeutics (AUTL) EPS (Basic) (2017 - 2025)
Autolus Therapeutics (AUTL) posted quarterly EPS (Basic) of -$0.34 for Q4 2025, down 213.82% year-on-year from $0.3 in Q4 2024, and down 14.21% on a QoQ basis from -$0.3 in Q3 2025.
Autolus Therapeutics (AUTL) EPS (Basic) (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has reported EPS (Basic) for 9 consecutive years, with -$0.34 the latest figure, recorded in Q4 2025.
- Quarterly EPS (Basic) fell 213.82% year-over-year to -$0.34 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.08 (down 24.94% YoY) and the FY2025 annual result came in at -$1.08, down 24.94% from the prior year.
- EPS (Basic) fell to -$0.34 in Q4 2025 per AUTL's latest filing, from -$0.3 in the prior quarter.
- Over the last five years, EPS (Basic) for AUTL reached as high as -$0.11 in Q4 2024 and fell as low as -$0.58 in Q4 2021.
- A 5-year average of -$0.34 and a median of -$0.3 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 75.61% — and 2025, when it tumbled 213.82%.
- Year by year, EPS (Basic) stood at -$0.58 in 2021, then soared by 50.91% to -$0.28 in 2022, then plunged by 56.21% to -$0.44 in 2023, then jumped by 75.61% to -$0.11 in 2024, then slumped by 213.82% to -$0.34 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.34, -$0.3, and -$0.18 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -0.22 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.26 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.47 |
| Jun 30, 2022 | -0.46 |
| Mar 31, 2022 | -0.41 |
| Dec 31, 2021 | -0.58 |
| Sep 30, 2021 | -0.47 |
| Jun 30, 2021 | -0.47 |
| Mar 31, 2021 | -0.53 |